New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 18, 2013
10:55 EDTKITD, KITD, CDTI, CDTI, ICUI, ICUI, STMP, STMP, XPL, XPL, XRS, XRS, YOD, YOD, COA, COA, HZNP, HZNP, ICPW, ICPW, BDSI, BDSIRoth Capital to host a conference
25th Annual Roth Conference is being held in Dana Point, California on March 17-20 with webcasted company presentations to begin on March 18 at 11 am; not all company presentations may be webcasted. Webcast Link
News For KITD;ICPW;HZNP;COA;YOD;XRS;XPL;STMP;ICUI;CDTI;BDSI From The Last 14 Days
Check below for free stories on KITD;ICPW;HZNP;COA;YOD;XRS;XPL;STMP;ICUI;CDTI;BDSI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
07:54 EDTHZNPLeerink to hold a conference
Subscribe for More Information
September 19, 2014
16:57 EDTHZNPHorizon Pharma files automatic ordinary share shelf
10:46 EDTHZNPHorizon Pharma backs FY15 revenue view $380M-$405M, consensus $376.94M
Backs FYT15 adjusted EBITDA view $150M-$170M
10:45 EDTHZNPHorizon Pharma backs FY14 revenue view $270M-$280M, consensus $277.56M
Subscribe for More Information
September 18, 2014
19:50 EDTHZNPHorizon Pharma trading halted, pending news
Subscribe for More Information
09:19 EDTHZNPHorizon Pharma announces holder approval of Vidara acquisition
Subscribe for More Information
September 17, 2014
08:44 EDTBDSIBioDelivery Sciences remains takeout candidate for Endo, says Summer Street
Summer Street believes a potential takeover of BioDelivery Sciences (BDSI) by partner Endo (ENDP) is no less likely after Endo made a bid to acquire Auxilium (AUXL). The firm believes an Endo buyout of BioDelivery is likely a 2015 event when BioDelivery's Bunavail for opioid dependence is on the market and BEMA Buprenorphine is facing FDA approval. Summer Street says it is a buyer of BioDelivery Sciences on weakness this morning and keeps a Buy rating on the name with a $28 price target.
07:48 EDTXPLDenver Gold Group to hold a forum
Subscribe for More Information
September 16, 2014
06:21 EDTHZNPHorizon Pharma to host special shareholder meeting
Special shareholder meeting to consider and seek shareholder approval of the acquisition of Vidara Therapeutics, will be held in Deerfield, IL on September 18 at 9 am.
September 15, 2014
08:12 EDTHZNPHorizon Pharma valuation at attractive entry point, says Cowen
Subscribe for More Information
September 10, 2014
16:33 EDTICPWRonald Chez reports 9.2% stake in Ironclad, urges exploration of alternatives
On September 10, Ronald Chez sent the following e-mail to Vane Clayton, Chairman of the Board of the Company: “I have reviewed Ironclad Performance's September 10 press release regarding the lawsuit that had been brought against Jeff Cordes, the company’s CEO and William Aisenberg, the company’s CFO in connection with their prior employment. I believe that, in addition to reviewing and investigating those matters, and focusing on the current operations of Ironclad Performance Wear Corporation, that the Board of Directors of the company should retain an investment banking firm to assist the company in exploring strategic alternatives."
September 9, 2014
10:09 EDTHZNPHorizon Pharma initiated with an Outperform at Avondale (pre-open)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use